nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—STK10—renal vein—nephrolithiasis	0.245	0.345	CbGeAlD
Gefitinib—STK10—renal artery—nephrolithiasis	0.165	0.232	CbGeAlD
Gefitinib—Cutaneous vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0461	0.159	CcSEcCtD
Gefitinib—CYP2C19—urine—nephrolithiasis	0.0236	0.0333	CbGeAlD
Gefitinib—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0229	0.0788	CcSEcCtD
Gefitinib—CYP2C9—urine—nephrolithiasis	0.0183	0.0258	CbGeAlD
Gefitinib—ERBB3—nephron tubule—nephrolithiasis	0.0161	0.0227	CbGeAlD
Gefitinib—MKNK2—nephron tubule—nephrolithiasis	0.0153	0.0215	CbGeAlD
Gefitinib—IRAK1—nephron tubule—nephrolithiasis	0.0153	0.0215	CbGeAlD
Gefitinib—ERBB3—renal system—nephrolithiasis	0.0146	0.0206	CbGeAlD
Gefitinib—CSNK1E—cortex of kidney—nephrolithiasis	0.0143	0.0201	CbGeAlD
Gefitinib—ERBB3—kidney—nephrolithiasis	0.0141	0.0199	CbGeAlD
Gefitinib—CYP3A4—urine—nephrolithiasis	0.014	0.0197	CbGeAlD
Gefitinib—MKNK2—renal system—nephrolithiasis	0.0139	0.0196	CbGeAlD
Gefitinib—CYP2D6—urine—nephrolithiasis	0.0138	0.0194	CbGeAlD
Gefitinib—MKNK2—cortex of kidney—nephrolithiasis	0.0131	0.0184	CbGeAlD
Gefitinib—IRAK1—cortex of kidney—nephrolithiasis	0.0131	0.0184	CbGeAlD
Gefitinib—MKNK1—cortex of kidney—nephrolithiasis	0.0129	0.0182	CbGeAlD
Gefitinib—STK10—renal system—nephrolithiasis	0.0113	0.0159	CbGeAlD
Gefitinib—STK10—kidney—nephrolithiasis	0.0109	0.0154	CbGeAlD
Gefitinib—MAP2K5—cortex of kidney—nephrolithiasis	0.0095	0.0134	CbGeAlD
Gefitinib—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00925	0.0319	CcSEcCtD
Gefitinib—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00921	0.0317	CcSEcCtD
Gefitinib—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.008	0.0276	CcSEcCtD
Gefitinib—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00794	0.0274	CcSEcCtD
Gefitinib—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00786	0.0271	CcSEcCtD
Gefitinib—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00786	0.0271	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0077	0.0265	CcSEcCtD
Gefitinib—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.0074	0.0255	CcSEcCtD
Gefitinib—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00677	0.0233	CcSEcCtD
Gefitinib—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00667	0.023	CcSEcCtD
Gefitinib—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00654	0.0225	CcSEcCtD
Gefitinib—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00641	0.0221	CcSEcCtD
Gefitinib—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00634	0.0218	CcSEcCtD
Gefitinib—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00604	0.0208	CcSEcCtD
Gefitinib—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00595	0.0205	CcSEcCtD
Gefitinib—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00571	0.0197	CcSEcCtD
Gefitinib—ABCG2—nephron tubule—nephrolithiasis	0.0054	0.00761	CbGeAlD
Gefitinib—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00539	0.0186	CcSEcCtD
Gefitinib—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00534	0.0184	CcSEcCtD
Gefitinib—CYP3A5—nephron tubule—nephrolithiasis	0.00501	0.00706	CbGeAlD
Gefitinib—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00486	0.0167	CcSEcCtD
Gefitinib—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0048	0.0165	CcSEcCtD
Gefitinib—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00474	0.0163	CcSEcCtD
Gefitinib—CYP1A1—renal system—nephrolithiasis	0.00466	0.00657	CbGeAlD
Gefitinib—Cough—Hydrochlorothiazide—nephrolithiasis	0.00459	0.0158	CcSEcCtD
Gefitinib—CYP3A5—renal system—nephrolithiasis	0.00456	0.00642	CbGeAlD
Gefitinib—CYP1A1—kidney—nephrolithiasis	0.00451	0.00635	CbGeAlD
Gefitinib—CYP3A5—kidney—nephrolithiasis	0.00441	0.00621	CbGeAlD
Gefitinib—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00438	0.0151	CcSEcCtD
Gefitinib—CYP3A5—cortex of kidney—nephrolithiasis	0.00429	0.00605	CbGeAlD
Gefitinib—Shock—Hydrochlorothiazide—nephrolithiasis	0.00422	0.0145	CcSEcCtD
Gefitinib—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.0042	0.0145	CcSEcCtD
Gefitinib—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00409	0.0141	CcSEcCtD
Gefitinib—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00401	0.0138	CcSEcCtD
Gefitinib—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00382	0.0132	CcSEcCtD
Gefitinib—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00373	0.0128	CcSEcCtD
Gefitinib—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0037	0.0127	CcSEcCtD
Gefitinib—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00367	0.0126	CcSEcCtD
Gefitinib—Pain—Hydrochlorothiazide—nephrolithiasis	0.00367	0.0126	CcSEcCtD
Gefitinib—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00351	0.0121	CcSEcCtD
Gefitinib—CYP3A4—renal system—nephrolithiasis	0.00342	0.00482	CbGeAlD
Gefitinib—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00341	0.0117	CcSEcCtD
Gefitinib—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00339	0.0117	CcSEcCtD
Gefitinib—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00339	0.0117	CcSEcCtD
Gefitinib—CYP2D6—renal system—nephrolithiasis	0.00337	0.00474	CbGeAlD
Gefitinib—CYP3A4—kidney—nephrolithiasis	0.00331	0.00466	CbGeAlD
Gefitinib—CYP2D6—kidney—nephrolithiasis	0.00325	0.00458	CbGeAlD
Gefitinib—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00316	0.0109	CcSEcCtD
Gefitinib—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00308	0.0106	CcSEcCtD
Gefitinib—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00304	0.0105	CcSEcCtD
Gefitinib—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00294	0.0101	CcSEcCtD
Gefitinib—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00939	CcSEcCtD
Gefitinib—Rash—Hydrochlorothiazide—nephrolithiasis	0.00271	0.00932	CcSEcCtD
Gefitinib—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0027	0.00931	CcSEcCtD
Gefitinib—ABCB1—nephron tubule—nephrolithiasis	0.00266	0.00375	CbGeAlD
Gefitinib—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00255	0.00878	CcSEcCtD
Gefitinib—ABCB1—renal system—nephrolithiasis	0.00242	0.00341	CbGeAlD
Gefitinib—ABCB1—kidney—nephrolithiasis	0.00234	0.0033	CbGeAlD
Gefitinib—ABCB1—cortex of kidney—nephrolithiasis	0.00228	0.00321	CbGeAlD
